BSE filing, NSE: GOPALA. Summary written from the filing by ALFA Finder's alert engine.
HCP Plastene Bulkpack Ltd: key numbers
- Share price
- ₹310.35
- Market cap
- ₹331.3 Cr
- Revenue (annual)
- ₹587.5 Cr
- Net profit (annual)
- ₹23.20 Cr
- P/E (TTM)
- 10.0×Sector 43.1×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 3.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from HCP Plastene Bulkpack Ltd
All →HCP Plastene Bulkpack Other Announcement
HCP Plastene Bulkpack Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing provides the company's equity distribution across various categories.
HCP Plastene Bulkpack Management Change
The Board appointed Mr. Prakash Hiralal Parekh as CFO of the company. Additionally, M/s. Nirav Patel & Associates was appointed as the new internal auditor.
HCP Plastene Bulkpack Annual General Meeting
HCP Plastene Bulkpack Limited concluded its 42nd Annual General Meeting on September 25, 2026. Shareholders approved all resolutions including re-appointments and increasing borrowing limits to Rs. 500 Crore.
HCP Plastene Bulkpack Annual Report
HCP Plastene Bulkpack Limited has filed its Annual Report for the financial year 2025-2026. This submission includes the notice for the upcoming 42nd Annual General Meeting.
HCP Plastene Bulkpack Other Announcement
HCP Plastene Bulkpack Limited is dispatching a letter with the web-link for its 42nd Annual Report to shareholders with unregistered email addresses for regulatory compliance.
HCP Plastene Bulkpack Annual General Meeting
HCP Plastene Bulkpack Limited announced its 42nd Annual General Meeting scheduled for September 25, 2026. The meeting will address financial adoption and related party transactions.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date